Clinical Trial Update: Vivitrol Treatment for Cannabis Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Vivitrol for cannabis use disorder was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Cannabis Use Disorder | Phase 2 | Status: TERMINATED | Results posted: 2025-02-07